Skip to main content

RAPT Therapeutics, Inc.

RAPTDelisted Mar 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001673772

RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding RAPT Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of RAPT: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders85185+1
Shares28.0M3.47K29.7M+1.70M (+6.1%)
Value$616.1M$76.0K$542.7M−$73.2M (−11.9%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to RAPT in Q2 2022
InstitutionSharesValue% of portfolio
UBS Oconnor LLC78,750$1.44M0.02%
ExodusPoint Capital Management, LP52,622$960.0K0.01%
Man Group plc–$374.0K0.00%
State Board of Administration of Florida Retirement System18,631$340.0K0.00%
Ergoteles LLC12,600$230.0K0.01%
UBS Asset Management Americas Inc11,982$218.7K0.00%
Algert Global LLC11,565$211.0K0.02%
Trustees of the University of Pennsylvania10,031$183.0K0.22%
Quantbot Technologies LP5,870$107.0K0.01%
Group One Trading, L.P.232$4.00K0.00%
Signaturefd, LLC33$1.00K0.00%

Sold out (10)

Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of RAPT in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Velan Capital Investment Management LP110,000$2.42M
Rafferty Asset Management, LLC83,733$1.84M
Renaissance Technologies LLC45,500$1.00M
J. Goldman & Co LP39,491$868.0K
Susquehanna International Group, LLP26,608$585.0K
Franklin Resources Inc12,705$280.0K
Invesco Ltd.9,523$209.0K
DuPont Capital Management Corp7,836$172.0K
Aquatic Capital Management LLC300$7.00K
Covestor Ltd9$0

Not filed for Q2 2022 yet (1)

Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RAPT in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Amalgamated Financial Corp.3,469$76.0K